Welcome to LookChem.com Sign In|Join Free

CAS

  • or

174072-89-0

Post Buying Request

174072-89-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

174072-89-0 Usage

General Description

ETHYL 2-AMINO-4-METHYL-5-(4-NITRO-PHENYL)-THIOPHENE-3-CARBOXYLATE is a chemical compound with a molecular formula C14H14N2O4S. It is a derivative of thiophene and contains an ethyl ester group, an amino group, a methyl group, and a nitrophenyl group. ETHYL 2-AMINO-4-METHYL-5-(4-NITRO-PHENYL)-THIOPHENE-3-CARBOXYLATE is commonly used in organic synthesis and pharmaceutical research. It has potential applications in the development of drugs targeting various diseases and conditions. Its specific properties and potential uses may vary depending on the specific research and development goals of the user.

Check Digit Verification of cas no

The CAS Registry Mumber 174072-89-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,0,7 and 2 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 174072-89:
(8*1)+(7*7)+(6*4)+(5*0)+(4*7)+(3*2)+(2*8)+(1*9)=140
140 % 10 = 0
So 174072-89-0 is a valid CAS Registry Number.
InChI:InChI=1/C14H14N2O4S/c1-3-20-14(17)11-8(2)12(21-13(11)15)9-4-6-10(7-5-9)16(18)19/h4-7H,3,15H2,1-2H3

174072-89-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-amino-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate

1.2 Other means of identification

Product number -
Other names 2-amino-4-methyl-5-(4-nitrophenyl)-thiophen-3-carboxylic acid ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:174072-89-0 SDS

174072-89-0Relevant articles and documents

Preparation method of Rugolix key intermediate

-

Paragraph 0058-0061, (2020/08/02)

The invention relates to a preparation method of a Rugolix key intermediate. 4-nitrophenyl acetic acid is used as a raw material, and a target product is obtained through four steps of reaction. The preparation method avoids the use of toxic reagents and has the advantages of mild reaction conditions, low cost, high yield and simple route and is suitable for industrial large-scale production.

Substituted pyrimidinedione compound and application thereof

-

, (2020/11/25)

The invention belongs to the technical field of medicines, and relates to a substituted pyrimidinedione compound and application thereof, and a pharmaceutical composition containing the compound, which can be used as a gonadotropin releasing hormone receptor antagonist. The invention also relates to a method for preparing the compound and the pharmaceutical composition, and application of the compound and the pharmaceutical composition in prevention or treatment of sex hormone dependent diseases including but not limited to prostate cancer, endometriosis, hysteromyoma, precocious puberty and the like.

Phenyl-substituted thieno[2,3-d]pyrimidine-2,4 (1H,3H)-dione compounds and application thereof

-

Paragraph 0143; 0149-0153, (2020/09/09)

The invention belongs to the technical field of medicines, and relates to phenyl-substituted thieno[2,3-d]pyrimidine-2,4 (1H,3H)-dione compounds, application thereof, and a pharmaceutical compositioncontaining the compounds. The compounds and the pharmaceutical composition can be used as gonadotropin releasing hormone receptor antagonists. The invention also relates to a method for preparing thecompounds and the pharmaceutical composition, and application of the compounds and the pharmaceutical composition in prevention or treatment of sex hormone dependent diseases including but not limitedto prostate cancer, endometriosis, hysteromyoma, precocious puberty and the like.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 174072-89-0